Stallergenes Greer acquires Stallergenes Greer

Stallergenes Greer agreed to acquire Stallergenes Greer. Reported deal value: Undisclosed. Status: Announced. Sector: Immunotherapy. Target headquarters context: Baar, Zug, Switzerland.

This page summarizes publicly available information about the transaction as of 2026-01-07. Figures and status may change as filings and press coverage update.

Stallergenes Greer , a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l. , an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy